Wilson Sonsini Goodrich & Rosati has advised Netskope, and Goodwin has advised the underwriters. Netskope has announced the pricing of its initial public offering, raising approximately...
Netskope Prices $1 Billion Initial Public Offering
Centerbridge Partners to Acquire MeridianLink in $2 Billion All-Cash Transaction
Kirkland & Ellis has advised Centerbridge Partners, and Goodwin Procter has advised MeridianLink. Skadden has advised Thoma Bravo, MeridianLink, Inc.’s largest shareholder. Paul Hastings LLP represented...
Prime Medicine Closes $144 Million Public Offering of Common Stock
Goodwin Procter, Foley Hoag, Honigman, and Wilson Sonsini Goodrich & Rosati have advised Prime Medicine Inc. on the offering, and Paul Hastings has advised the underwriters....
Rise Baking Company’s Acquisition of Table Talk Pies
Locke Lord advised Table Talk Pies on the transaction, and Kirkland & Ellis advised Olympus Partners. Leading bakery manufacturer, Rise Baking Company announced the acquisition of...
TPI Composites, Inc.’s Refinancing Transaction with Oaktree
Lazard acted as TPI’s financial advisor. Goodwin Procter LLP acted as TPI’s legal advisor and Sullivan & Cromwell LLP acted as Oaktree’s legal advisor. TPI Composites,...
Seagen and Nurix’s Strategic Collaboration
Goodwin advised Seagen on the deal. Nurix Therapeutics, Inc. (Nasdaq: NRIX) announced that it has entered into a multi-year, multi-target strategic collaboration agreement with Seagen Inc....
Nimbus Therapeutics’ $210 Million Private Financing
Goodwin advised Nimbus Therapeutics on the financing. Nimbus Therapeutics announced its $210 million private financing to advance its next wave of tech-enabled small molecule medicines. The...
ImmunityBio’s $40 Million Common Stock Offering
Wilson Sonsini advised ImmunityBio, and Goodwin advised the placement agent. ImmunityBio, Inc. (NASDAQ: IBRX) announced that it has executed financing to provide further working capital and support...
Brainstorm Cell Therapeutics’ $7.5 Million Common Stock Direct Offering
Goodwin advised BrainStorm on the offering, and Ellenoff Grossman advised the placement agent. BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI) announced its registered direct offering of 4,054,055...
Akero Therapeutics’s $220 Million Registered Direct Offering
Goodwin advised Akero Therapeutics on the offering, and Cooley advised the underwriter involved. Akero Therapeutics (Nasdaq: AKRO) announced the closing of its underwritten registered direct offering...
Latch’s Acquisition of Honest Day’s Work
Goodwin advised Honest Day’s Work on the deal. Latch, Inc. (NASDAQ: LTCH) announced that it has entered into a definitive agreement to acquire Honest Day’s Work...
BridgeBio Pharma’s $150 Million Common Stock Public Offering
Goodwin Procter advised BridgeBio Pharma on the offering, and Latham & Watkins advised the underwriters involved. BridgeBio Pharma, Inc. announced the pricing on March 7, 2023 of...